nach oben

Current Bladder Dysfunction Reports

Erschienen in:

01.12.2014 | Neurogenic Bladder (CR Powell, Section Editor)

Prevention of Urinary Tract Infection for Patients with Neurogenic Bladder

verfasst von: Lindsey Cox, Anne P. Cameron

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Urinary tract infection is a common problem among patients with neurogenic bladder dysfunction that can be costly and challenging to manage. Current literature on the topic of preventing urinary tract infections in this heterogeneous patient population is challenged by the difficulty in defining urinary tract infections and by the lack of long-term data from controlled randomized studies. New research suggests that intradetrusor injection of onabotulinumtoxin A may be a useful adjunct in preventing urinary tract infections, and further studies are needed to determine if probiotics, bacterial interference, and/or vaccines will prove to be of use in the population.

Manack A, Motsko SP, Haag-Molkenteller C, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn. 2011;30(3):395–401. doi:10.1002/nau.21003.PubMedCrossRef

Larsen LD, Chamberlin DA, Khonsari F, Ahlering TE. Retrospective analysis of urologic complications in male patients with spinal cord injury managed with and without indwelling urinary catheters. Urology. 1997;50(3):418–22. doi:10.1016/S0090-4295(97)00224-0.PubMedCrossRef

3.••

Esclarín De Ruz A, García Leoni E, Herruzo Cabrera R. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol. 2000;164(4):1285–9. Prospective study of 128 patients with spinal cord injury to idenfity risk factors for developing urinary tract infection

Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. J Spinal Cord Med. 2009;32(5):568–73.PubMedCentralPubMed

Waites KB, Canupp KC, DeVivo MJ. Eradication of urinary tract infection following spinal cord injury. Paraplegia. 1993;31(10):645–52. doi:10.1038/sc.1993.104.PubMedCrossRef

The prevention and management of urinary tract infections among people with spinal cord injuries. National Institute on Disability and Rehabilitation Research Consensus Statement. January 27–29, 1992. J Am Paraplegia Soc. 1992;15(3):194–204.

Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol. 2012;187(2):391–7. doi:10.1016/j.juro.2011.10.020.PubMedCrossRef

Madden-Fuentes R, McNamara E. Variation in definitions of urinary tract infections in spina bifida patients: a systematic review. Pediatrics. 2013;132(1):132–9. doi:10.1542/peds.2013-0557.PubMedCrossRef

Evans CT, Rogers TJ, Chin A, et al. Antibiotic prescribing trends in the emergency department for veterans with spinal cord injury and disorder 2002–2007. J Spinal Cord Med. 2013;36(5):492–8. doi:10.1179/2045772312Y.0000000076.PubMedCentralPubMedCrossRef

10.

Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25(3):584–99.PubMedCrossRef

11.

Chaudhry R, Madden-Fuentes RJ, Ortiz TK, et al. Inflammatory response to Escherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J Urol. 2014;191(5):1454–61. doi:10.1016/j.juro.2013.12.013.PubMedCrossRef

12.

Scholes D, Hawn TR, Roberts PL, et al. Family history and risk of recurrent cystitis and pyelonephritis in women. J Urol. 2010;184(2):564–9. doi:10.1016/j.juro.2010.03.139.PubMedCentralPubMedCrossRef

13.

Singh R, Rohilla RK, Sangwan K, Siwach R, Magu NK, Sangwan SS. Bladder management methods and urological complications in spinal cord injury patients. Indian J Orthop. 2011;45(2):141–7. doi:10.4103/0019-5413.77134.PubMedCentralPubMedCrossRef

14.

Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010;184(1):213–7. doi:10.1016/j.juro.2010.03.008.PubMedCrossRef

15.

Mahajan ST, Frasure HE, Marrie RA. The prevalence of urinary catheterization in women and men with multiple sclerosis. J Spinal Cord Med. 2013;36(6):632–7. doi:10.1179/2045772312Y.0000000084.PubMedCentralPubMedCrossRef

16.

Cardenas DD, Moore KN, Dannels-McClure A, et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM R. 2011;3(5):408–17. doi:10.1016/j.pmrj.2011.01.001.PubMedCrossRef

17.

Barber DB, Woodard FL, Rogers SJ, Able AC. The efficacy of nursing education as an intervention in the treatment of recurrent urinary tract infections in individuals with spinal cord injury. SCI Nurs. 1999;16(2):54–6.PubMed

18.

Fink HA, Wilt TJ, Eidman KE, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158(7):535–43. doi:10.7326/0003-4819-158-7-201304020-00005.PubMedCrossRef

19.•

Wyndaele J-J, Brauner A, Geerlings SE, Bela K, Peter T, Bjerklund-Johanson TE. Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int. 2012;110(11 Pt C):E910–7. doi:10.1111/j.1464-410X.2012.11549.x. Review of urinary tract infection prevention strategies.PubMedCrossRef

20.

Everaert K, Lumen N, Kerckhaert W. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg. 2009;64(4):335–40.PubMedCrossRef

21.•

Brumbaugh A, Mobley H. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines. 2012;11(6):663–76. doi:10.1586/erv.12.36. Comprehensive review of the current status of a vaccine for Escherichia coli.PubMedCentralPubMedCrossRef

22.

Pearman JW, Bailey M, Riley LP. Bladder instillations of trisdine compared with catheter introducer for reduction of bacteriuria during intermittent catheterisation of patients with acute spinal cord trauma. Br J Urol. 1991;67(5):483–90.PubMedCrossRef

23.

Anderson RU. Prophylaxis of bacteriuria during intermittent catheterization of the acute neurogenic bladder. J Urol. 1980;123(3):364–6.PubMed

24.

Van den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. Pediatr Surg Int. 2011;27(7):781–5. doi:10.1007/s00383-011-2913-5.PubMedCrossRef

25.•

Van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. Int J Antimicrob Agents. 2010;36(6):485–90. doi:10.1016/j.ijantimicag.2010.05.005. Case report and systematic review reporting that gentamicin instillations are likely safe and may be an effective treatment for selected patients with recurrent urinary tract infections.PubMedCrossRef

26.

Penders J, Huylenbroeck AAY, Everaert K, Van Laere M, Verschraegen GLC. Urinary infections in patients with spinal cord injury. Spinal Cord. 2003;41(10):549–52. doi:10.1038/sj.sc.3101499.PubMedCrossRef

27.

Weld KJ, Dmochowski RR. Effect of bladder management on urological complications in spinal cord injured patients. J Urol. 2000;163(3):768–72.PubMedCrossRef

28.

Afsar SI, Yemisci OU, Cosar SNS, Cetin N. Compliance with clean intermittent catheterization in spinal cord injury patients: a long-term follow-up study. Spinal Cord. 2013;51(8):645–9. doi:10.1038/sc.2013.46.PubMedCrossRef

29.

Pickard R, Lam T, MacLennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012;380(9857):1927–35. doi:10.1016/S0140-6736(12)61380-4.PubMedCrossRef

30.

Hunter KF, Bharmal A, Moore KN. Long-term bladder drainage: suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn. 2013;32(7):944–51. doi:10.1002/nau.22356.PubMedCrossRef

31.

Bermingham SL, Hodgkinson S. Intermittent self catheterisation with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ: Br Med J. 2013. doi:10.1136/bmj.e8639.

32.

Li L, Ye W, Ruan H, Yang B, Zhang S. Impact of hydrophilic catheters on urinary tract infections in people with spinal cord injury: systematic review and meta-analysis of randomized controlled trials. Arch Phys Med Rehabil. 2013;94(4):782–7. doi:10.1016/j.apmr.2012.11.010.PubMedCrossRef

33.

Chartier-Kastler E, Amarenco G, Lindbo L, et al. A prospective, randomized, crossover, multicenter study comparing quality of life using compact versus standard catheters for intermittent self-catheterization. J Urol. 2013;190(3):942–7. doi:10.1016/j.juro.2013.04.026.PubMedCrossRef

34.

Castelló T, Girona L, Gómez MR, Mena Mur A, García L. The possible value of ascorbic acid as a prophylactic agent for urinary tract infection. Spinal Cord. 1996;34(10):592–3.PubMedCrossRef

35.

Lee BSB, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10(10), CD003265. doi:10.1002/14651858.CD003265.pub3.PubMed

36.

Gupta K, Chou MY, Howell A, Wobbe C, Grady R, Stapleton AE. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol. 2007;177(6):2357–60. doi:10.1016/j.juro.2007.01.114.PubMedCentralPubMedCrossRef

37.

Jepson RG, Williams G, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2012;10, CD001321. doi:10.1002/14651858.CD001321.pub5.PubMed

38.

Mutlu H, Ekinci Z. Urinary tract infection prophylaxis in children with neurogenic bladder with cranberry capsules: randomized controlled trial. ISRN Pediatr. 2012;2012(1):317280. doi:10.5402/2012/317280.PubMedCentralPubMed

39.

Gallien P, Amarenco G, Benoit N, et al. Cranberry versus placebo in the prevention of urinary infections in multiple sclerosis: a multicenter, randomized, placebo-controlled, double-blind trial. Mult Scler. 2014. doi:10.1177/1352458513517592.PubMed

40.

Kranjčec B, Papeš D, Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014;32(1):79–84. doi:10.1007/s00345-013-1091-6.PubMedCrossRef

41.

Lüthje P, Brauner H, Ramos NL, et al. Estrogen supports urothelial defense mechanisms. Sci Transl Med. 2013;5(190):190ra80. doi:10.1126/scitranslmed.3005574.PubMed

42.

Grin PM, Kowalewska PM, Alhazzan W, Fox-Robichaud AE. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013;20(1):6607–14.PubMed

43.

Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006;24(1):28–32. doi:10.1007/s00345-005-0043-1.PubMedCrossRef

44.

Anukam KC, Hayes K, Summers K, Reid G. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-Alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study. Adv Urol. 2009;2009:680363. doi:10.1155/2009/680363.PubMedCentralCrossRef

45.

Gamé X, Castel-Lacanal E, Bentaleb Y, et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol. 2008;53(3):613–8. doi:10.1016/j.eururo.2007.08.039.PubMedCrossRef

46.•

Jia C, Liao L-M, Chen G, Sui Y. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord. 2013;51(6):487–90. doi:10.1038/sc.2012.180. Case series providing evidence for the use of intradetrusor botulinum toxin injection for preventing urinary tract infections in patients with neurogenic bladder.PubMedCrossRef

47.

Mouttalib S, Khan S, Castel-Lacanal E, et al. Risk of urinary tract infection after detrusor botulinum toxin A injections for refractory neurogenic detrusor overactivity in patients with no antibiotic treatment. BJU Int. 2010;106(11):1677–80. doi:10.1111/j.1464-410X.2010.09435.x.PubMedCrossRef

48.

Niël-Weise BS, van den Broek PJ, da Silva EMK, Silva LA. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev. 2012;8, CD004201. doi:10.1002/14651858.CD004201.pub3.PubMed

49.

Hull R, Rudy D, Donovan W, et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol. 2000;163(3):872–7.PubMedCrossRef

50.

Sundén F, Håkansson L, Ljunggren E, Wullt B. Escherichia coli 83972 bacteriuria protects against recurrent lower urinary tract infections in patients with incomplete bladder emptying. J Urol. 2010;184(1):179–85. doi:10.1016/j.juro.2010.03.024.PubMedCrossRef

51.

Darouiche RO, Green BG, Donovan WH, et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6. doi:10.1016/j.urology.2011.03.062.PubMedCrossRef

Titel: Prevention of Urinary Tract Infection for Patients with Neurogenic Bladder
verfasst von: Lindsey Cox
Anne P. Cameron
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 4/2014
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-014-0257-4

Neu im Fachgebiet Urologie

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Patient Selection, Operative Technique, and Contemporary Outcomes of Continent Catheterizable Diversion: the Indiana Pouch

Nocturia in the Elderly

Role of Urodynamics in the Evaluation of Elderly Voiding Dysfunction

Stress Urinary Incontinence in the Elderly: Evaluation, Surgical Treatment, and Management of Postoperative Voiding Dysfunction